Comparison of metabolic and prolactin variables from a six-month randomised trial of olanzapine and quetiapine in schizophrenia

Adverse effects of prolactin in rodents and humans: breast and prostate cancer

(2008) Philip W. Harvey et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A review of the association between antipsychotic use and hyperprolactinaemia

(2008) Chris Bushe et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

(2008) René S Kahn et al.   LANCET

Antipsychotic effects on estimated 10-year coronary heart disease risk in the CATIE schizophrenia study

(2008) Gail L. Daumit et al.   SCHIZOPHRENIA RESEARCH

Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH

Change in metabolic syndrome parameters with antipsychotic treatment in the CATIE Schizophrenia Trial: Prospective data from phase 1

(2008) Jonathan M. Meyer et al.   SCHIZOPHRENIA RESEARCH